HEADACHE RELIEF
- Product NDC
- 41226-370
- 11-digit product format
- 412260370
- Labeler code
- 41226
- Product ID
- 41226-370_3992e879-0f22-1e3f-e063-6294a90a67f8
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- ACETAMINOPHEN, ASPIRIN AND CAFFEINE
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Labeler
- Kroger Company
- Application
- M012
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2021-04-10
- Substance
- CAFFEINE; ASPIRIN; ACETAMINOPHEN
- Active strength
- 65; 250; 250 mg/1; mg/1; mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 41226-370-42 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 41226-370-01 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 41226-370-42 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 41226-370-01 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 41226-370-42 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 41226-370-01 | 0efc9e666f02… | f202fb6c5f17… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- HEADACHE RELIEF
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| CAFFEINE | 65 mg/1 |
| ASPIRIN | 250 mg/1 |
| ACETAMINOPHEN | 250 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 3G6A5W338E | Internal UNII lookup |
| R16CO5Y76E | Internal UNII lookup |
| 362O9ITL9D | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 308297 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| bbed29a1-3c52-3531-e053-2995a90a686c | Available on FDA.report |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 41226-370-01 | 2025-02-14 | 370R Headache Relief Caplets KROGER 41226 370 |
| 41226-370-42 | 2025-02-14 | 370R Headache Relief Caplets KROGER 41226 370 |
| 41226-370-01 | 2025-01-30 | 370R Headache Relief Caplets KROGER 41226 370 |
| 41226-370-42 | 2025-01-30 | 370R Headache Relief Caplets KROGER 41226 370 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 41226-370-01 | HEADACHE RELIEF | 100 in 1 BOTTLE | TABLET, COATED | 100 | 4 | |
| 41226-370-01 | HEADACHE RELIEF | 1 in 1 CARTON | TABLET, COATED | 1 | 4 | |
| 41226-370-42 | HEADACHE RELIEF | 1 in 1 CARTON | TABLET, COATED | 1 | 4 | |
| 41226-370-42 | HEADACHE RELIEF | 24 in 1 BOTTLE | TABLET, COATED | 24 | 4 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| basic care daytime severe cold and flu nighttime severe cold and flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE, DOXYLAMINE SUCCINATE | Amazon.com Services LLC | 9f4daadb-fdaf-4ea9-bad9-7ed9f8cee7f2 | 2024-11-15 | Warnings | M012 |
| Rompe Pecho EX | GUAIFENESIN | Efficient Laboratories Inc | 89ea23a5-0da7-407e-83d9-77a0b562f3af | 2024-11-14 | Warnings | M012 |
| basic care daytime cold and flu nighttime cold and flu | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL | Amazon.com Services LLC | ceb342da-ff6d-4c19-9f78-0033d028075e | 2024-11-14 | Warnings | M012 |
| Topcare Nite Time Day Time Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL | Topco Associates LLC | efb8e0e2-0795-4f4a-8ca6-955f33bee143 | 2024-11-14 | Warnings | M012 |
| good neighbor pharmacy nasal four | PHENYLEPHRINE HYDROCHLORIDE | Amerisource Bergen | a3d637dc-d957-458c-8a75-f948601a31aa | 2024-11-14 | Warnings | M012 |
| nasal | OXYMETAZOLINE HYDROCHLORIDE | Meijer Distribution Inc | ec8db98f-4fd1-4644-b76f-ff04f72e87f4 | 2024-11-13 | Warnings | M012 |
| dg health tussin | DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE | Dolgencorp, LLC | 6f9b8267-1e0b-430b-8e44-06408ae82ea4 | 2024-11-13 | Warnings | M012 |
| Walgreens Effervescent Cold Relief Plus | ASPIRIN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE BITARTRATE | Walgreens | b60e2cf9-11ec-469e-e053-2a95a90a712a | 2024-11-13 | Warnings | M012 |
| Kroger Effervescent Cold Relief | ASPIRIN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE BITARTRATE | Kroger Company | 69333774-3cf4-384d-e053-2a91aa0a48b3 | 2024-11-13 | Warnings | M012 |
| Effervescent Orange Cold Relief | ASPIRIN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE BITARTRATE | H. E. Butt Grocery Company | 6403fe3d-d82b-f4d5-e053-2991aa0ac7d6 | 2024-11-13 | Warnings | M012 |
| Effervescent Cold Relief | ASPIRIN, CHLORPHENIRAMINE MALEATE, PHYLEPHRINE BITARTRATE | Topco Associates LLC | a2929bcb-fa81-4f15-b087-a9996b5e7d1f | 2024-11-13 | Warnings | M012 |
| Equate Effervescent Cold Relief | ASPIRIN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE BITARTRATE | Walmart | 6271bb48-74b2-eb57-e053-2991aa0afd1b | 2024-11-13 | Warnings | M012 |
| Equaline Effervescent Cold Relief | ASPIRIN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE BITARTRATE | United Natural Foods, Inc. dba UNFI | 6bf341e0-94b1-08ff-e053-2991aa0af634 | 2024-11-13 | Warnings | M012 |
| Good Sense Effervescent Cold Relief | ASPIRIN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE BITARTRATE | Good Sense | cd25e250-bb8b-7e83-e053-2a95a90a2639 | 2024-11-13 | Warnings | M012 |
| Top Value Effervescent Cold Relief | ASPIRIN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE BITARTRATE | Tower Laboratories Ltd | 440a00b1-7960-0cc4-e054-00144ff8d46c | 2024-11-13 | Warnings | M012 |
| Top Value Effervescent Cold Relief - Orange | ASPIRIN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE BITARTRATE | Tower Laboratories Ltd. | c6f207e8-bc0d-853a-e053-2a95a90ac623 | 2024-11-13 | Warnings | M012 |
| Effervescent Orange Cold Relief | ASPIRIN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE BITARTRATE | DOLGENCORP, LLC | 7fad8e65-34fe-5313-e053-2a91aa0a56f4 | 2024-11-13 | Warnings | M012 |
| Dollar General Effervescent Cold Relief | ASPIRIN, CHLORPHENIRAMINE MALEATE, PHYLEPHRINE BITARTRATE | DOLGENCORP, LLC | 7face5c7-f5c7-7eee-e053-2991aa0ab064 | 2024-11-13 | Warnings | M012 |
| Quality Choice Effervescent Cold Relief Plus | ASPIRIN, CHLORPHENIRAMINE MALEATE, AND PHENYLEPHRINE BITARTRATE | Chain Drug Marketing Association | 90622927-9682-4eb0-8c7f-894230b3dda4 | 2024-11-13 | Warnings | M012 |
| Quality Choice Effervescent Cold Relief - Orange | ASPIRIN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE BITARTRATE | Chain Drug Marketing Association | 9f7d76f0-4f1c-a1c7-e053-2a95a90a3dca | 2024-11-13 | Warnings | M012 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 308297 | acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet | PSN | bbed29a1-3c52-3531-e053-2995a90a686c | 4 |
| 308297 | acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet | SCD | bbed29a1-3c52-3531-e053-2995a90a686c | 4 |
| 308297 | APAP 250 MG / ASA 250 MG / caffeine 65 MG Oral Tablet | SY | bbed29a1-3c52-3531-e053-2995a90a686c | 4 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 41226-370-01 | 41226037001 | 1 BOTTLE in 1 CARTON (41226-370-01) / 100 TABLET, COATED in 1 BOTTLE | 1 bottle | 2021-04-10 | 0000-00-00 | No | No | Current |
| 41226-370-42 | 41226037042 | 1 BOTTLE in 1 CARTON (41226-370-42) / 24 TABLET, COATED in 1 BOTTLE | 1 bottle | 2021-04-10 | 0000-00-00 | No | No | Current |